The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.
Price target range & 52-week position
Bear₩1,520.93Fair value₩3,075.20Bull₩6,543.33
FairClose
52-week traded range
52W low ₩2,185.0052W high ₩6,650.00
The 52-week range is measured from the stored price history, not estimated.
Valuation summary
Trading below the consensus fair value
SELVAS Healthcare, Inc. closed at ₩2,280.00, 25.9% below the consensus fair value of ₩3,075.20 drawn from 8 valuation models.
Financial DNA score 49/100 — Average. P/E of 15.1x against the 20x sector multiple the P/E model uses.
Quantitative summary only — not investment advice.
All valuation models
DCF Valuation
₩2,997.20
+31.5%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=9%, r=10%, tg=3%, n=10yr
Graham Number
₩3,073.55
+34.8%
√(22.5 × EPS × BVPS)
EPS=151, BVPS=2780.49
Graham Formula
₩6,543.33
+187.0%
EPS × (8.5 + 2g) × 4.4 ÷ FD_Rate
g=12%, FD=3.3%
P/E Fair Value
₩3,020.00
+32.5%
EPS × 20x (sector P/E)
EPS=151, Sector P/E=20x
Peter Lynch (PEG)
₩1,812.00
-20.5%
EPS × Growth% (PEG = 1 is fair)
EPS=151, g=12%
Book Value (P/B)
₩1,520.93
-33.3%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=2780.49, ROE=5.5%, g=6%, r=10%
Reverse DCF
₩2,280.00
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 3.4% | Historical: 12%
Margin of Safety
₩2,931.39
+28.6%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=3908.52, MoS=25%
Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.
Educational data only. Not a recommendation to buy, sell or hold any security.